Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed agreements to acquire two companies in the AI-enabled drug discovery space: Cyclica and Valence. “Recursion has pioneered the massive, parallel generation of […]

Read More

What is the purpose of story-telling?

I was very pleased to receive, on a recent occasion [that accidentally happened to be my birthday!] a document sent to me by email, that told me (in so many words) that someone had been so inspired, or impressed, with my use of such devices as folk tal…

Read More